616.00GBp-1.91%Mkt Cap: 744.86M GBpP/E: —Last update: 2026-06-01
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system wh…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap744.86M GBp
Enterprise Value809.55M GBp
Revenue (TTM)168.74M GBp
Gross Profit65.98M GBp
Net Income (TTM)-30.13M GBp
Revenue/Share1.508 GBp
Last Price616.00 GBp
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees977
CountryGB
SectorHealthcare
IndustryBiotechnology
ISINGB00BDFBVT43
Valuation
P/E (Trailing)—
P/E (Forward)49.72
PEG—
EV/EBITDA-44.33
EV/Revenue4.80
P/S4.50
P/B8.31
EPS (TTM)-0.27
EPS (Forward)0.13
52W Range
305.5047% of range962.00
52W High962.00 GBp
52W Low305.50 GBp
Profitability
Gross Margin39.10%
Oper. Margin-7.88%
EBITDA Margin-10.82%
Profit Margin-17.85%
ROE-32.98%
ROA-9.25%
Growth
Revenue Growth22.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF507.00K GBp
CapEx (TTM)4.76M GBp
FCF Margin-0.01%
FCF Yield-0.00%
Net Debt51.23M GBp
Net Debt/EBITDA-2.81
Balance Sheet
Debt/Equity1.62
Current Ratio2.20
Quick Ratio1.92
Book Value/Sh0.7560 GBp
Cash/Share0.8020 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:50
Split DateMay 30, 2018
Analyst Consensus
Rating—
Target (Mean)842.86 GBp
Target Range550.00 GBp – 1170.00 GBp
# Analysts7
Ownership
Shares Out.120.92M
Float60.81M
Insiders20.83%
Institutions55.17%
Technical
SMA 50604.24 (+1.9%)
SMA 200645.15 (-4.5%)
Beta1.09
S&P 52W Chg27.94%
Avg Vol (30d)273.88K
Avg Vol (10d)224.03K
Technical Indicators
RSI (14)53.4
MACD1.3073
MACD Signal0.4741
MACD Hist.+0.8333
BB Upper660.34 GBp
BB Middle622.00 GBp
BB Lower583.66 GBp
BB Width12.33%
ATR (14)30.49 GBp
Vol Ratio (20d)2.57x